SSY Group Limited (HKG:2005)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 8.17B -3.6% |
| Revenue (ttm) | 4.38B -4.4% |
| Net Income | 507.45M -23.0% |
| EPS | 0.17 -21.7% |
| Shares Out | 2.89B |
| PE Ratio | 16.18 |
| Forward PE | 14.13 |
| Dividend | 0.08 (2.83%) |
| Ex-Dividend Date | Sep 10, 2026 |
| Volume | 6,326,000 |
| Open | 2.815 |
| Previous Close | 2.770 |
| Day's Range | 2.775 - 2.850 |
| 52-Week Range | 2.010 - 3.180 |
| Beta | 0.53 |
| Analysts | Strong Buy |
| Price Target | 3.93 (+39.12%) |
| Est. Earnings | Nov 26, 2026 |
About SSY Group
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical... [Read more]
Financial Performance
In 2025, SSY Group's revenue was 4.17 billion, a decrease of -27.85% compared to the previous year's 5.77 billion. Earnings were 470.64 million, a decrease of -55.65%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for 2005 stock is "Strong Buy." The 12-month stock price target is $3.93, which is an increase of 39.12% from the latest price.
News
SSY Group Earnings release: H1 2026
SSY Group released its H1 2026 earnings on August 26, 2026, summarizing the period's financial results.
SSY Group Slides: H1 2026
SSY Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 26, 2026.
SSY Group Quarterly report: H1 2026
SSY Group has published its H1 2026 quarterly earnings report on August 26, 2026.
SSY Group FY25 Profit Drops On Weak Revenues; Cuts Dividend- Update
(RTTNews) - SSY Group Ltd., (LJUIF, 2005.HK), a Chinese pharmaceutical manufacturer, reported Friday lower profit in fiscal 2025 with weak revenues. The company also announced a cut in dividend.
SSY Group Earnings release: H2 2025
SSY Group released its H2 2025 earnings on March 27, 2026, summarizing the period's financial results.
SSY Group Slides: H2 2025
SSY Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 27, 2026.
SSY Group Annual report: H2 2025
SSY Group has published its H2 2025 annual report on March 27, 2026.
SSY Group 9-months Profit Falls
(RTTNews) - SSY Group Ltd., (LJUIF,2005.HK) an investment holding company, on Tuesday reported a sharp decline in profit for the nine-month period, ended September 30, as the results were hurt by weak...
SSY Group Secures Approval For Levamlodipine Besilate Tablets For Hypertension Treatment In China
(RTTNews) - SSY Group Limited announced that it has received approvals for the production and registration of Levamlodipine Besilate Tablets (5mg and 2.5mg) from the National Medical Products Administ...